OVILLA-MARTINEZ, Roberto et al. Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting. The Journal of Infection in Developing Countries, [S. l.], v. 16, n. 01, p. 63–72, 2022. DOI: 10.3855/jidc.15126. Disponível em: https://jidc.org/index.php/journal/article/view/35192523. Acesso em: 27 nov. 2024.